Cortexin

14 indexed publications · 8 human studies · research from 1999 to 2026

Research goals studied

  • Bone, muscle & performance
  • Immune function
  • Metabolic & glucose
  • Mood, stress & sleep
  • Neuro & cognition

Studies referencing Cortexin

  • Cortexin in the Comprehensive Therapy of Alcohol-Related Disorders

    2026 · Human evidence

    Clinical report from a 2025 treatment cohort; full protocol and controlled-comparison details require review.

  • Efficacy and Safety of Cortexin as Additional Therapy in Patients with Depressive Disorder

    2026 · Human evidence

    The indexed report describes Cortexin as adjunctive therapy; independent replication and full protocol appraisal are needed.

  • Therapeutic Equivalence of Intravenous and Intramuscular Cortexin in Acute Ischemic Stroke

    2025 · Human evidence

    Reported intravenous administration as non-inferior to intramuscular administration for functional recovery outcomes.

  • Neurotropic Effects of Cortexin on Models of Mental and Neurological Disorders

    2025 · Preclinical

    Reported neurobehavioral effects across animal models; findings are preclinical.

  • Cortexin Effects in a High-Glucose Model of Peripheral Neuropathy

    2023 · Preclinical

    Examined Cortexin under high-glucose injury conditions; this is mechanistic preclinical evidence.

  • Comparative Efficacy of Cellex and Cortexin in Patients with Chronic Cerebral Ischemia

    2020 · Human evidence

    Compared two peptide-containing preparations on neurological and cognitive outcomes.

  • Dose-Dependent Effects of Cortexin in Chronic Cerebral Ischemia

    2018 · Human evidence

    Reported dose-related changes in neurological, asthenic, sleep, anxiety and depressive symptoms in 189 patients.

  • Results of a Multicenter Study on the Efficacy of Cortexin in Children with Cognitive and Behavioral Disorders

    2018 · Human evidence

    The study included 635 children and reported improvements across selected clinical scales; blinding and control details require full-text review.

  • Molecular Mechanisms of Brain Peptide-Containing Drugs

    2018 · Preclinical

    Reviews proposed antioxidant, anti-inflammatory and neurotrophic mechanisms of brain peptide preparations.

  • Peptide Drug Cortexin Inhibits Brain Caspase-8

    2017 · Preclinical

    Reported stronger inhibition of caspase-8 than several other proteases in the studied model.

  • An Open Clinical Trial of Cortexin in Treatment of Brain Ischemia with Cognitive and Affective Disorders

    2014 · Human evidence

    Evaluated cognitive and affective outcomes in brain ischemia; open-label design limits causal inference.

  • Pinealon and Cortexin in Rats with Carotid Artery Occlusion

    2011 · Preclinical

    Compared Pinealon and Cortexin in a carotid-occlusion model.

  • Comparison of Behavioral Effects of Cortexin and Cerebrolysin Injected into Brain Ventricles

    2007 · Preclinical

    Both preparations produced psychoactivating effects in rats; Cortexin effects were stronger in the reported tests.

  • Cortexin in the Treatment of Circulatory Encephalopathy

    1999 · Human evidence

    Early clinical report; details require review of the Russian-language full text.

Working with Cortexin?

Convert a vial to draw volume on the peptide calculator, or track protocols and vials in the free app.

Start tracking free